Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/29499
Title: The prevalence of CALR mutations in a cohort of patients with myeloproliferative neoplasms
Authors: Grinsztejn, E
Percy, M J
McClenaghan, D
Quintana, M
Cuthbert, R J G
McMullin, M F
Affilliation: Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil./ Universidade Federal do Io de Janeiro. Faculdade de Medicina. Rio de Janeiro, Brasil./ Queens University of Belfast. Belfast, UK.
Belfast City Hospital. Haematology. Belfast, UK.
Belfast City Hospital. Haematology. Belfast, UK.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil
Belfast City Hospital. Haematology. Belfast, UK.
Queens University of Belfast. Belfast, UK./ Belfast City Hospital. Haematology. Belfast, UK.
Abstract: To investigate the prevalence of calreticulin (CALR) mutations in JAK2- and MPL-non-mutated patients with suspected myeloproliferative neoplasm (MPN) from a large MPN clinic and confirm a diagnosis of MPN.
Keywords: Myeloproliferative
Calreticulin
Mutations
Prevalence
Prognosis
Issue Date: 2016
Citation: GRINSZTEJN, E. et al. The prevalence of CALR mutations in a cohort of patients with myeloproliferative neoplasms. International Journal of Laboratory Hematology, v. 38, n. 1, p. 102-106, 2016
DOI: 10.1111/ijlh.12447
ISSN: 1751-5521
Copyright: restricted access
Appears in Collections:INI - Artigos de Periódicos



FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.